Health Enterprises Network (HEN) and Advanced Manufacturing and Logistics Network (AML) celebrated the graduation of 26 ...
M2T-CD33 (LTI-214) has received FDA orphan drug designation, offering incentives like tax credits and market exclusivity for AML treatment. The treatment targets CD33, a glycoprotein present in 90% of ...
On September 19, 2025, the Department of the Treasury’s Financial Crimes Enforcement Network (FinCEN) issued a notice of proposed rulemaking (NPRM) that would amend the investment adviser anti-money ...
Two of the largest organizations representing investment advisers and asset managers are voicing support for a federal proposal to postpone new anti-money laundering requirements for RIAs, while ...
Q3 2025 Management View James Dentzer, President and CEO, emphasized continued progress in the TakeAim Lymphoma study evaluating emavusertib in combination with ibrutinib in primary CNS lymphoma ...
Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment ...
This week, we continue our look at how companies are using AI in their business operations and draw compliance lessons from this use for compliance professionals. Today, we continue with compliance ...
King and Spalding partner Matt Biben and counsel Joshua Roberts discuss the Bank Secrecy Act and evaluate potential reforms, ...
NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback